Abubakar, II;
White, PJ;
(2018)
Hepatitis C virus treatment as prevention in people who inject drugs.
[Rapid communication].
Lancet Infectious Diseases
, 18
(4)
p. 379.
10.1016/S1473-3099(18)30130-0.
Preview |
Text
Abubakar_Hepatitis C treatment update.pdf - Accepted Version Download (284kB) | Preview |
Abstract
Alexei Zelenev and colleagues presented an elegant analysis of treatment-as-prevention (TasP) for hepatitis C virus (HCV) infection in people who inject drugs (PWID),1 using a model capturing the dynamics of the injecting-partnership network, which is superior to the more common approaches of compartmental modelling (omitting network structure) and static network modelling (omitting changes in partnerships over time).
| Type: | Article |
|---|---|
| Title: | Hepatitis C virus treatment as prevention in people who inject drugs |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S1473-3099(18)30130-0 |
| Publisher version: | https://doi.org/10.1016/S1473-3099(18)30130-0 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10045818 |
Archive Staff Only
 |
View Item |
